Contact
Please use this form to send email to PR contact of this press release:
Primary Central Nervous System Lymphoma (PCNSL) Survey from The End Brain Cancer Initiative and Ono Pharma
TO:
Dellann Elliott Mydland
End brain cancer Initiative
+ +1 425-444-2215